SCHEDULE: Baillie Gifford Discloses 5.75% Stake in Tempus AI

Baillie Gifford & Co. has filed an amended Schedule 13G, reporting a 5.75% beneficial ownership stake in Tempus AI, Inc.'s Class A Common Stock.

Summary

• Baillie Gifford & Co., an investment adviser based in the United Kingdom, reported beneficial ownership of 9,692,441 shares of Tempus AI, Inc. Class A Common Stock.
• This ownership represents 5.75% of the Class A Common Stock outstanding.
• Baillie Gifford & Co. holds sole voting power over 9,662,493 shares and sole dispositive power over 9,692,441 shares.
• The securities are held on behalf of investment advisory clients, including investment companies, employee benefit plans, pension funds, or other institutional clients.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Tempus AI, Inc.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a reputable institutional investor like Baillie Gifford & Co. is generally viewed positively, indicating confidence in the company's value proposition, although it does not provide operational or financial performance details.

Positives

• A significant institutional investor like Baillie Gifford & Co. holding a 5.75% stake can signal confidence in Tempus AI, Inc.'s long-term prospects.
• The passive nature of the filing (Schedule 13G) indicates that Baillie Gifford & Co. is not seeking to influence control, suggesting a long-term investment horizon.

Risks

• This filing does not contain specific risks related to Tempus AI, Inc.'s operations or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance from Tempus AI, Inc. or Baillie Gifford & Co. regarding the issuer's future performance.

Industry Context

The disclosure of a significant stake by a prominent investment adviser like Baillie Gifford & Co. in Tempus AI, Inc., a company operating in the healthcare AI and technology sector, highlights continued institutional interest in innovative companies leveraging artificial intelligence for medical advancements and data analysis.

Stakeholder Impact

• Shareholders may view this as a positive signal, potentially increasing confidence in the company's stock due to significant institutional backing.
• The presence of a large, passive institutional investor can contribute to market stability for the stock.

Key Dates

Recommendation

This Schedule 13G filing indicates a significant, passive institutional investment by Baillie Gifford & Co. in Tempus AI, Inc. While a large institutional stake can be a positive signal of confidence, this filing alone does not provide sufficient operational or financial performance data to warrant a 'buy' or 'sell' recommendation. It primarily serves as a disclosure of ownership, suggesting a 'hold' position for existing investors and a signal for potential investors to conduct further due diligence on Tempus AI's fundamentals.

Keywords

Tempus AI, Baillie Gifford, Beneficial Ownership, Institutional Investment, Class A Common Stock, SEC Filing, Investment Adviser, Healthcare Technology, AI